ImmuPharma plc (LON:IMM – Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 5.43 and traded as high as GBX 9.70. ImmuPharma shares last traded at GBX 9.26, with a volume of 5,849,270 shares changing hands.
ImmuPharma Stock Up 9.3%
The company has a market capitalization of £50.88 million, a P/E ratio of -11.37 and a beta of 1.53. The business has a fifty day moving average price of GBX 10.98 and a 200 day moving average price of GBX 5.43.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Articles
- Five stocks we like better than ImmuPharma
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Amazon Is One of the Clearest Buys If the Market Dips Again
- Most Volatile Stocks, What Investors Need to Know
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- Growth Stocks: What They Are, Examples and How to Invest
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
